ArticleBritish journal of cancer2018

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.

Jaffer A Ajani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.